Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "Inexpensive treatments https://simplemedrx.top"

Looking for quality documents?
publications icon
Continuous Manufacturing: A Changing Processing Paradigm
By Randi Hernandez BioPharm International
publications icon
Developing an Integrated Continuous Bioprocessing Platform: Interview with Konstantin Konstantinov
By Maribel Rios BioProcess International
publications icon
Special Report on Continuous Bioprocessing: Upstream, Downstream, Ready for Prime Time?
By Angelo DePalma BioProcess International
publications icon
Reducing Clinical-Phase Manufacturing Costs: Collaborating for Savings without Compromising Quality or Performance Publication
In downstream purification of monoclonal antibodies (MAbs), the single greatest contributor to manufacturing costs is the expensive capture step typically based on protein A affinity chromatography. Almost since its introduction to bioprocessing, efforts have been made to reduce the cost of this step.
publications icon
Reducing Clinical-Phase Manufacturing Costs: Collaborating for Savings without Compromising Quality or Performance White Paper
By Dana Pentia et al. BioProcess International 14(1)
publications icon
Prepacked Chromatography Columns: Evaluation for Use in Pilot and Large-Scale Bioprocessing Publication
Time to market, resource requirements, cost, and flexibility are key considerations in designing purification processes suitable for manufacturing biopharmaceutical products. 
publications icon
Accelerating analytical testing for GMP plasmid production
The challenges associated with gene therapy bioprocessing are numerous and burdensome, from scalability to Cost of Goods control, and from ensuring quality/consistency to accessing sufficient capacity and expertise. The consensus of opinion in the field is that a largely or fully automated process based upon a single, easy-to-use platform would be optimal, as would the adoption of single-use technology. The majority of challenges that arise with testing of gene therapy materials relate to time and accuracy. The CTech™ SoloVPE® and FlowVPX® slope spectroscopy technology is specifically designed to address these very issues Speaker: Paul Mania
publications icon
Advancing real-time monitoring of AAV vector processes
Q&A Podcast and write-up for Biomanufacturing experts which include Rachel Legmann, Director of Technology for Gene Therapy and Joe Ferraiolo, At-Line Director Bioanalytics Applications. Authors: Rachel Legmann, Joe Ferraiolo
event icon
10th BioProduction Congress
Convention Center – Cité Internationale
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support